Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
| Status: | Completed |
|---|---|
| Conditions: | Acne, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | January 2011 |
| End Date: | July 2012 |
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of
ANT-1207 in the treatment of acne.
Inclusion Criteria:
- diagnosis of moderate to severe facial acne
- 15 to 40 papules and pustules, and 5 to 50 open and/or closed comedones
- no presence of nodules
- female subjects must be not pregnant and non-lactating
Exclusion Criteria:
- presence of 1 or more nodules
- use of topical steroids on the face 4 weeks prior and during the study
- use of systemic corticosteroids 6 weeks prior and during the study
- topical or systemic acne treatment in the 4 weeks prior to Baseline
We found this trial at
16
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials